Clinical Trials Directory

Trials / Completed

CompletedNCT04053998

Benchmarking Outcomes in Pancreatic Surgery - WhippleBenchmarks.Org

Benchmarking Outcomes in Pancreatoduodenectomy With Portal Vein Resection - WhippleBenchmarks.Org

Status
Completed
Phase
Study type
Observational
Enrollment
1,462 (actual)
Sponsor
Royal Free Hospital NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The WhippleBenchmark 2 Collaborative study aims at defining benchmark criteria for best achievable outcomes after pancreaticoduodenectomy with portal vein resection.

Detailed description

Pancreatoduodenectomy (PD) with portal vein resection (PVR) is performed for the achievement of complete resection (R0) in patients with locally advanced pancreatic head lesions. Despite most commonly performed in high-volume pancreatic surgery centers by experienced surgeons, best achievable outcomes, such as morbidity and mortality, following such complex procedure remain unknown. The aim is to conduct a retrospective multicenter cohort study to define benchmark values for best achievable outcomes following duodenopancreatectomy (DP) with portal vein resection (PVR). Data collection and study design are based on to the well established standardized reporting for benchmarking (Sánchez-Velázquez et. al. Ann Surg, February 2019 ). This multicenter cohort study will include all consecutive pancreaticoduodenectomies with portal vein resections from at least 20 high volume centers performing over 50 pancreatic operations per year or 150 cases within 3 years from at least 3 continents over a period of 10 years (2009-2019). Every center included in the study must have a prospective database from which data can be collected as well as previous publications critically reporting on their outcome.

Conditions

Interventions

TypeNameDescription
PROCEDUREPancreaticoduodenectomy with portal vein resectionPancreatic surgery with vein resection to achieve disease clearance.

Timeline

Start date
2019-08-09
Primary completion
2020-02-10
Completion
2020-02-20
First posted
2019-08-13
Last updated
2020-11-20

Locations

2 sites across 2 countries: Spain, United Kingdom

Source: ClinicalTrials.gov record NCT04053998. Inclusion in this directory is not an endorsement.